Dressed Up Diagnostics?
Executive Summary
Nanogen's positioning of its in-development molecular biology workstation as a genomics tool as well as an IVD instrument helped it raise $82.5 million in a FOPO--an extraordinary amount for a company long-considered a diagnostics instrument maker. In that way, it 'caught the wave' of the excitement over genomics that hit the stock market in early 2000.You may also be interested in...
Generics Firms Deterred From Continuous Manufacturing
Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.
Does Polivy Provide A Cure For DLBCL? Too Early To Say, Argue NICE Experts
Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.
Back With A Bang: ‘Brexit Bill’ For UK’s Medical Devices Due For 2nd Reading On 2 March
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports